Characterizing antibodies for cancer research
Proteomic and Antibody Production and Characterization
This study is looking at how antibodies work in cancer research to help create better tests and treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project ID | NIH-10490799 on NIH RePORTER |
What this research studies
This research focuses on the comprehensive characterization of antibodies used in cancer research through advanced techniques like Mass Spectrometry. The Antibody Characterization Laboratory at the Frederick National Laboratory will establish a Proteomic Characterization Laboratory to analyze proteins and their interactions in cancer. By developing targeted assays, the research aims to improve the understanding of antibody responses and their applications in clinical settings. Patients may benefit from enhanced diagnostic and therapeutic tools derived from this work.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals diagnosed with cancer who may be involved in clinical trials related to antibody therapies.
Not a fit: Patients with non-cancerous conditions or those not involved in antibody-related therapies may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer diagnostics and treatments through better understanding and utilization of antibodies.
How similar studies have performed: Other research in antibody characterization and proteomics has shown promise in improving cancer treatment strategies, indicating a potential for success in this approach.
Where this research is happening
Frederick, United States
- Leidos Biomedical Research, INC. — Frederick, United States (Active)
Researchers
- Principal investigator: Dmitrovsky, Ethan — Leidos Biomedical Research, INC.
- Study coordinator: Dmitrovsky, Ethan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.